NOS3 and cancer: PCK family plays a key role in tumour promotion and progression and it is an ideal target for cancer therapy [14].PCK β activation blocks insulin-induced endothelial nitric oxide synthase (eNOS) stimulation, whereas inhibition of PKC β restores vascular function in animal models [15].